Indications and uses
temporarily relieves these symptoms associated with the common cold or flu: headache fever sinus pressure nasal congestion minor body aches and pains
temporarily relieves these symptoms associated with the common cold or flu: headache fever sinus pressure nasal congestion minor body aches and pains
do not take more than directed the smallest effective dose should be used adults and children 12 years of age and over: take 1 caplet every 4 to 6 hours while symptoms persist. If symptoms do not respond to 1 caplet, 2 caplets may be used. do not use more than 6 caplets in any 24-hour period unless directed by a doctor children under 12 years of age: do not use
store at 20 - 25° C (68 - 77° F). Avoid excessive heat above 40° C (104° F). read all warnings and directions before use. Keep carton.
Drug Facts
temporarily relieves these symptoms associated with the common cold or flu:
Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:
If an allergic reaction occurs, stop use and seek medical help right away.
This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:
NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.
If pregnant or breast-feeding,ask a health professional before use. It is especially important not to use ibuprofen during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
Keep out of reach of children.In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
acacia, calcium carbonate, carnauba wax, confectioner's sugar, corn starch, croscarmellose sodium, crospovidone, FD&C Blue no. 2 Aluminum Lake, FD&C Red no. 40 Aluminum Lake, FD&C Yellow no. 6 Aluminum Lake, gelatin, guar gum, hydrogenated vegetable oil, hydroxypropyl cellulose, iron oxide black, kaolin, polyethylene glycol, powdered cellulose, povidone, pregelatinized starch, propylene glycol, shellac, silicon dioxide, sodium benzoate, sucrose, talc, titanium dioxide, white wax
call 1-800-406-7984
Distributed by: Ohm Laboratories Inc.
North Brunswick, NJ 08902
NDC: 63629-5284-1: 30 Tablets in a BOTTLE
NDC: 63629-5284-2: 20 Tablets in a BOTTLE
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63629-5284-1 | 2022-02-16 | C162847 | 48780-1 | 9855e2a2-3f51-60a7-e053-dbdaa90a05bd | Ibuprofen and Pseudoephedrine hydrochloride |
| 63629-5284-2 | 2022-02-16 | C162847 | 48780-1 | 9855e2a2-3f51-60a7-e053-dbdaa90a05bd | Ibuprofen and Pseudoephedrine hydrochloride |
| 63629-5284-1 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-3f51-60a7-e053-dbdaa90a05bd | Ibuprofen and Pseudoephedrine hydrochloride |
| 63629-5284-2 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-3f51-60a7-e053-dbdaa90a05bd | Ibuprofen and Pseudoephedrine hydrochloride |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| IBUPROFEN | ACTIVE INGREDIENT | WK2XYI10QM | 1000 | |
| PSEUDOEPHEDRINE HYDROCHLORIDE | ACTIVE INGREDIENT | 6V9V2RYJ8N | 1000 | |
| IBUPROFEN | ACTIVE MOIETY | WK2XYI10QM | 1000 | |
| PSEUDOEPHEDRINE | ACTIVE MOIETY | 7CUC9DDI9F | 1000 | |
| ACACIA | INACTIVE INGREDIENT | 5C5403N26O | 1000 | |
| CALCIUM CARBONATE | INACTIVE INGREDIENT | H0G9379FGK | 1000 | |
| CARNAUBA WAX | INACTIVE INGREDIENT | R12CBM0EIZ | 1000 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | 1000 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | 1000 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | 1000 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | 1000 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | 1000 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | 1000 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | 1000 | |
| GUAR GUM | INACTIVE INGREDIENT | E89I1637KE | 1000 | |
| HYDROXYPROPYL CELLULOSE | INACTIVE INGREDIENT | RFW2ET671P | 1000 | |
| KAOLIN | INACTIVE INGREDIENT | 24H4NWX5CO | 1000 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | 1000 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | 1000 | |
| POWDERED CELLULOSE | INACTIVE INGREDIENT | SMD1X3XO9M | 1000 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | 1000 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1000 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | 1000 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | 1000 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | 1000 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 1000 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 1000 | |
| WHITE WAX | INACTIVE INGREDIENT | 7G1J5DA97F | 1000 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63629-5284 | 63629-5284-1, 63629-5284-2 |
| 51660-423 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, DELAYED RELEASE / ORAL | 1.7 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / ORAL | 602 mg | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, COATED / ORAL | 0.1 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, DELAYED RELEASE / ORAL | 66 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | CAPSULE, DELAYED RELEASE / ORAL | 0.02 mg | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, EXTENDED RELEASE / ORAL | 1 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE, EFFERVESCENT / ORAL | 60 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | SUSPENSION / ORAL | 900 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, LIQUID FILLED / ORAL | 12 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / ORAL | 22602 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | DROPS / ORAL | 0.2 mg/1ml | ||
| POVIDONES | POVIDONE | FZ989GH94E | TABLET, COATED / ORAL | 49.2 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | ELIXIR / ORAL | 5.02 mg/5ml | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | TABLET, COATED / ORAL | 3 mg | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, COATED / ORAL | NA | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, COATED PELLETS / ORAL | NA | ||
| HYDROXYPROPYL CELLULOSE | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET, COATED / ORAL | 13.6 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 24 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, EXTENDED RELEASE / ORAL | 67 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SOLUTION / ORAL | 42596 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SUSPENSION / ORAL | 160 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | SYRUP / ORAL | 4 mg/5ml | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, DELAYED RELEASE / ORAL | 36 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | ||
| HYDROXYPROPYL CELLULOSE | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | POWDER, FOR SUSPENSION / ORAL | 200 mg | ||
| FD&C BLUE NO. 2 | FD&C BLUE NO. 2 | L06K8R7DQK | TABLET, FILM COATED / ORAL | 2 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | TABLET, FILM COATED / ORAL | 1 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | CAPSULE, COATED PELLETS / ORAL | 198 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | TABLET, ORALLY DISINTEGRATING / ORAL | 12 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, COATED / ORAL | 40.2 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER, FOR SOLUTION / ORAL | 280 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, EXTENDED RELEASE / ORAL | 184 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | POWDER, FOR SUSPENSION / ORAL | 35 mg/5ml | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | FILM, SOLUBLE / ORAL | 2 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET, SUGAR COATED / ORAL | NA | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | SUSPENSION / ORAL | 100 mg/5ml | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 11 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET / ORAL | 30 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SOLUTION / ORAL | 98 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | CAPSULE / ORAL | 257 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | PASTE / ORAL | 28 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, DELAYED RELEASE / ORAL | 955 mg | ||
| ACACIA | ACACIA | 5C5403N26O | POWDER / ORAL | 800 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | POWDER, FOR SUSPENSION / ORAL | 6 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | CAPSULE, EXTENDED RELEASE / ORAL | 71 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | SUSPENSION / ORAL | 150 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, DELAYED RELEASE / ORAL | 3.2 mg | ||
| FERROSOFERRIC OXIDE | FERROSOFERRIC OXIDE | XM0M87F357 | CAPSULE, EXTENDED RELEASE / ORAL | 1.49 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, COATED / ORAL | 0.2 mg | ||
| CALCIUM CARBONATE | CALCIUM CARBONATE | H0G9379FGK | TABLET, FILM COATED / ORAL | 300 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | ELIXIR / ORAL | 5.4 mg/5ml | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | DROPS / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, COATED / ORAL | 516.42 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | CAPSULE, COATED PELLETS / ORAL | NA | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET, DELAYED RELEASE / ORAL | 30 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, COATED / ORAL | 17 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A074567-001 | IBUPROHM COLD AND SINUS | IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE | 200MG;30MG | TABLET / ORAL | 2001-04-17 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A074567-001 | IBUPROHM COLD AND SINUS | 200MG;30MG | TABLET / ORAL | 2001-04-17 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibuprofen and Pseudoephedrine hydrochloride | IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE | Ohm Laboratories Inc. | 65ec0f85-7ca3-4adc-b152-a0ae2fd0692f | 2025-02-27 | Warnings | 51660-423 |
| 8628adae-722a-4fb1-b066-6696e5ed951b | 7249b0f9-b24c-4f7f-81f2-22473a4d5b0c | 2024-01-15 | Warnings | 7249b0f9-b24c-4f7f-81f2-22473a4d5b0c |
Adverse event summaries are temporarily unavailable. Other product information remains available.